wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38577303-231B94A6-A5A6-4FF9-993D-529F1A7A689B
Q38577303-231B94A6-A5A6-4FF9-993D-529F1A7A689B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38577303-231B94A6-A5A6-4FF9-993D-529F1A7A689B
Empagliflozin/Linagliptin: A Review in Type 2 Diabetes.
P2860
Q38577303-231B94A6-A5A6-4FF9-993D-529F1A7A689B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38577303-231B94A6-A5A6-4FF9-993D-529F1A7A689B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfec0e35feaa8f937c2421cbbc213d5664872ea9
P2860
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.